Amarin | AMRN - 무역 채무자





무역 채무자 변화 날짜
AbbVie USD 12.59B 180M 2025-12
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
Amarin USD 126.83M 477K 2025-12
AstraZeneca USD 17.88B 1.17B 2026-03
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
DBV Technologies USD 15.97M 279K 2025-09
Esperion Therapeutics USD 140.19M 21.21M 2025-12
GlaxoSmithKline GBP 7.94B 178M 2026-03
Halozyme Therapeutics USD 457.99M 16.72M 2026-03
Heron Therapeutics USD 89.59M 8.54M 2025-12
Ionis Pharmaceuticals USD 74M 8M 2026-03
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Neurocrine Biosciences USD 768.1M 81.3M 2026-03
Novartis USD 9.6B 2.69B 2026-03